Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1184 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Etrolizumab for Crohn’s Disease	Etrolizumab (PRO145223; RG7413; rhuMAb Beta7)	Crohn's disease	Gastroenterology , Immunology	2021	View \| Download
Etrolizumab for treating moderately to severely active ulcerative colitis in adults	Etrolizumab (PRO145223; RG7413; rhuMAb Beta7)	Ulcerative colitis	Gastroenterology	2020	View \| Download
Evinacumab for homozygous familial hypercholesterolemia	Evinacumab (REGN1500)	Hyperlipidaemia	Endocrine Nutritional and Metabolic Disorders	2019	View \| Download
Evinacumab for treating homozygous familial hypercholesterolemia in children	Evinacumab (REGN1500)	Homozygous familial hypercholesterolemia	Endocrine Nutritional and Metabolic Disorders , Genetic Disorders	2022	View \| Download
Evobrutinib for treating relapsing multiple sclerosis	Evobrutinib	Multiple sclerosis (MS)	Neurology	2023	View \| Download
Evolocumab for preventing major cardiovascular events in adults with a high risk of cardiovascular events	Evolocumab	Cardiovascular events	Cardiovascular System	2023	View \| Download
Faricimab for diabetic macular oedema	Faricimab (RO6867461; RG 7716)	Diabetic macular oedema	Endocrine Nutritional and Metabolic Disorders , Ophthalmology	2020	View \| Download
Faricimab for macular oedema secondary to retinal vein occlusion	Faricimab (RO6867461; RG 7716)	Retinal Vein Occlusion	Ophthalmology	2022	View \| Download
Faricimab for neovascular age-related macular degeneration	Faricimab (RO6867461; RG 7716)	Age-related macular degeneration (AMD)	Ophthalmology	2020	View \| Download
Favezelimab-pembrolizumab for treating metastatic PD-L1 positive colorectal cancer	Favezelimab-pembrolizumab	Colorectal cancer	Gastrointestinal Cancer , Oncology	2023	View \| Download